Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
Saved in:
| Title: | Safety and effectiveness of disease-modifying therapies after switching from natalizumab. |
|---|---|
| Authors: | Zeineddine, Maya1,2 (AUTHOR), Al-Roughani, Raed3 (AUTHOR), Farouk Ahmed, Samar4 (AUTHOR), Khoury, Samia5 (AUTHOR), El-Ayoubi, Nabil5 (AUTHOR), Al-Mahdawi, Akram6 (AUTHOR), Al-Khabouri, Jaber7 (AUTHOR), Al-Asmi, Abdullah8 (AUTHOR), Chentouf, Amina9 (AUTHOR), Inshasi, Jihad10 (AUTHOR), Gouider, Riadh11 (AUTHOR), Mrabet, Saloua11 (AUTHOR), Shalaby, Nevin12 (AUTHOR), Massouh, Joelle13 (AUTHOR), Mohamed Ramzy Hasan Mohamed, Farah13 (AUTHOR), Al-Hajje, Amal14,15 (AUTHOR), Salameh, Pascale14,15,16 (AUTHOR), Dimassi, Hani14,15,16 (AUTHOR), Boumediene, Farid2 (AUTHOR), Yamout, Bassem13 (AUTHOR) yamoutba@gmail.com |
| Source: | Multiple Sclerosis Journal. Jul2024, Vol. 30 Issue 8, p1026-1035. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
